You should be evaluated for fatty liver if you have metabolic risk factors — type 2 diabetes or prediabetes, obesity or a large waist, high blood pressure, abnormal lipids, or metabolic syndrome — or if a fatty liver was found incidentally on a scan. Evaluation goes beyond confirming fat; it checks for fibrosis with a tool like FIB-4.
Section accent: --clay (MASLD pillar, scoped in-family).
The point of "who should be evaluated"
The goal of evaluation is not to prove there's fat in your liver — imaging often already shows that. The goal is to find out whether there is fibrosis (scarring), because fibrosis, not fat, is what changes your future. The real question is: who is likely enough to have at-risk liver disease that a fibrosis check is worthwhile?
The answer follows the biology. MASLD is metabolic disease, so the people who should be evaluated are the people carrying metabolic risk — plus anyone who's had a fatty liver spotted by accident. → What Is MASLD?
The metabolic risk profile — who's at higher risk
Any of the following raises the likelihood of MASLD, and the risk compounds when several cluster together:
- Obesity — particularly higher BMI, though BMI alone is an imperfect measure. → BMI, Body Fat & Body Composition
- Central adiposity (large waist). Where fat sits matters more than total weight; visceral fat drives liver fat. This is why waist circumference is part of the workup.
- Type 2 diabetes or prediabetes. One of the strongest associations — a majority of people with type 2 diabetes have MASLD, and diabetes raises the risk of progression to fibrosis. Diabetes is arguably the single most important reason to check. → MASLD & Diabetes
- Dyslipidemia — especially high triglycerides and low HDL.
- Hypertension.
- Metabolic syndrome — the cluster of central adiposity, high glucose, high blood pressure, high triglycerides and low HDL. Having the syndrome is essentially a flag for looking at the liver.
- Obstructive sleep apnea (OSA). Independently associated with MASLD and fibrosis, partly through intermittent low oxygen. → Weight & Sleep Apnea
- PCOS (polycystic ovary syndrome). Linked to insulin resistance and a higher MASLD risk in women. → PCOS & Weight
- Older age. Fibrosis prevalence rises with age (a fact that also complicates FIB-4 interpretation).
- Family history of MASLD or cirrhosis, and certain genetic factors (heritability is substantial).
- Established cardiovascular disease. The metabolic soil that scars the liver also injures arteries; the two travel together. → MASLD & Cardiovascular Risk
No single factor is a diagnosis. The pattern — several metabolic risks together — is what should prompt a structured evaluation. → The W8Experts Diagnostic Approach
Guideline-endorsed high-risk groups
Major guidelines (AASLD; EASL–EASD–EASO) specifically recommend proactively assessing liver-fibrosis risk in people with:
- Type 2 diabetes
- Obesity with metabolic risk factors, or metabolic syndrome
- Persistently abnormal liver enzymes or an incidentally discovered fatty liver
- (Depending on the pathway) a family history of cirrhosis or other elevated-risk features
For these groups, the recommended entry point is usually a FIB-4 score — cheap, calculated from routine bloodwork — rather than jumping straight to imaging or referral. → FIB-4 Explained
Incidental fatty liver — "my scan showed fat, now what?"
A very common way MASLD is discovered is by accident: a fatty (or "echogenic," "steatotic," "hepatic steatosis") liver noted on an ultrasound, CT or MRI done for something else entirely — abdominal pain, kidney stones, a gallbladder check.
This finding is worth acting on, but calmly. What it does and doesn't mean:
- What it tells you: there is fat in the liver. That's a real finding and a prompt.
- What it does NOT tell you: how much inflammation or scarring is present. Imaging that detects fat says little about fibrosis. An incidental "fatty liver" is a steatosis finding, not a fibrosis result.
- The right next step is usually to assess metabolic risk and run a FIB-4, not to assume either "it's nothing" or "my liver is failing." Both extremes are common and both are wrong.
Put plainly: an incidental fatty liver should trigger a fibrosis-risk check, not reassurance and not panic. → The W8Experts Diagnostic Approach · Do I Have Fatty Liver? (tool)
Normal enzymes don't get you off the hook
Many people are told their "liver tests are normal" and assume nothing further is needed. This is a genuine trap. ALT and AST are not fibrosis tests, and significant fibrosis can exist with completely normal enzymes. If you carry metabolic risk factors, normal enzymes alone do not rule out at-risk liver disease — which is exactly why FIB-4 (which weights age and platelets, not just enzymes) exists. → "My Liver Tests Are Normal…"
Who probably doesn't need an extensive workup
Equal-and-opposite honesty: not everyone needs testing, and over-testing has its own harms (false positives, anxiety, unnecessary referrals). A metabolically healthy person with no risk factors, no abnormal imaging and no abnormal labs generally does not need a fatty-liver evaluation. The pathway is designed to concentrate testing on higher-risk people and reassure the rest. → The W8Experts Diagnostic Approach
SIGNATURE — "What the evidence says: Who to evaluate"
- What we know: Metabolic risk factors — especially type 2 diabetes, obesity with metabolic risk, and metabolic syndrome — sharply raise MASLD and fibrosis risk; guidelines recommend fibrosis-risk assessment (starting with FIB-4) in these groups.
- What we think: Structured, risk-based screening catches at-risk fibrosis earlier, when it's more treatable, while sparing low-risk people unnecessary tests.
- What we don't know: The ideal screening interval, and how best to screen "lean" MASLD and some higher-risk ethnic and genetic groups.
- What patients should do: If you have metabolic risk or an incidental fatty liver, ask specifically about a fibrosis-risk assessment — not just "are my liver tests normal?" → FIB-4 Explained
Questions patients ask
Who should be screened for fatty liver?
People with type 2 diabetes or prediabetes, obesity or a large waist, metabolic syndrome, abnormal lipids, or an incidentally found fatty liver. Type 2 diabetes is one of the strongest reasons. Grade A 🟢
I have type 2 diabetes — should my liver be checked?
Yes. A majority of people with type 2 diabetes have MASLD, and diabetes raises the risk of progression to fibrosis, so guidelines recommend a fibrosis-risk assessment such as FIB-4. Grade A 🟢 → MASLD & Diabetes
My ultrasound showed a fatty liver by accident — is that serious?
It means there's fat in the liver, which is worth acting on, but it says nothing about scarring. The right next step is a fibrosis-risk check (FIB-4), not panic or dismissal. Grade A 🟢 → Diagnostic Approach
Can I have fatty liver if I'm not overweight?
Yes. "Lean MASLD" occurs, usually with visceral fat, insulin resistance or genetic factors. A normal BMI doesn't exclude it, so risk factors still matter. Grade B 🟡
Does PCOS increase fatty liver risk?
Yes. PCOS is linked to insulin resistance and a higher risk of MASLD, so it's a reasonable reason to assess metabolic and liver risk. Grade B 🟡 → PCOS & Weight
Is sleep apnea connected to fatty liver?
Obstructive sleep apnea is independently associated with MASLD and with fibrosis, likely partly through intermittent low oxygen. It adds to the risk picture. Grade B 🟡 → Weight & Sleep Apnea
My liver enzymes are normal — do I still need evaluation?
Possibly yes, if you have metabolic risk factors. Normal ALT/AST don't rule out fibrosis, which is why FIB-4 (weighting age and platelets) is used instead of enzymes alone. Grade A 🟢 → Normal Enzymes
Does high cholesterol or triglycerides raise fatty liver risk?
Abnormal lipids — especially high triglycerides and low HDL — are part of the metabolic profile that drives MASLD, so they count toward the risk picture. Grade A 🟢
Is fatty liver hereditary?
There's a substantial genetic component, and a family history of MASLD or cirrhosis raises your risk, though metabolic factors still dominate for most people. Grade B 🟡
Does everyone with a fatty liver need a FibroScan?
No. Most people start with FIB-4; only those with an indeterminate or high score, or other concerning features, proceed to elastography. The pathway concentrates testing where it helps. Grade A 🟢 → Diagnostic Approach
I'm metabolically healthy with no risk factors — should I be worried?
Probably not. Without metabolic risk, abnormal imaging or abnormal labs, an extensive fatty-liver workup usually isn't warranted. Over-testing has its own downsides. Grade B 🟡
KEEP READING
- The W8Experts Diagnostic Approach — the 4-step pathway once you've decided to evaluate.
- FIB-4 Explained — the usual first step, from routine bloodwork.
- "My Liver Tests Are Normal…" — why normal enzymes don't rule out disease.
- Do I Have Fatty Liver? (tool) — walk through your own risk picture.
- MASLD & Diabetes — why diabetes is the single strongest reason to check.
Written by Darius A. Schneider, MD, PhD · Board-Certified Endocrinologist (ECNU) · Last updated: 2026-08-10 · References: AASLD Practice Guidance on MASLD (2023); EASL–EASD–EASO clinical practice guidance; guideline recommendations for fibrosis-risk assessment in type 2 diabetes and metabolic syndrome. Educational; not individualized advice.
